191 related articles for article (PubMed ID: 25479728)
1. Reprint of "iPSCs, aging and age-related diseases".
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
[TBL] [Abstract][Full Text] [Related]
2. iPSCs, aging and age-related diseases.
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
[TBL] [Abstract][Full Text] [Related]
3. Aging in the mouse and perspectives of rejuvenation through induced pluripotent stem cells (iPSCs).
Isobe K; Cheng Z; Ito S; Nishio N
Results Probl Cell Differ; 2012; 55():413-27. PubMed ID: 22918818
[TBL] [Abstract][Full Text] [Related]
4. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
7. Primer and interviews: promises and realities of induced pluripotent stem cells.
Kiefer JC
Dev Dyn; 2011 Aug; 240(8):2034-41. PubMed ID: 21761486
[TBL] [Abstract][Full Text] [Related]
8. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.
Liu X; Li W; Fu X; Xu Y
Front Immunol; 2017; 8():645. PubMed ID: 28626459
[TBL] [Abstract][Full Text] [Related]
9. The application of induced pluripotent stem cells for bone regeneration: current progress and prospects.
Teng S; Liu C; Krettek C; Jagodzinski M
Tissue Eng Part B Rev; 2014 Aug; 20(4):328-39. PubMed ID: 24102431
[TBL] [Abstract][Full Text] [Related]
10. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
11. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells: progress towards a biomedical application.
Barile L; Altomare C; Zaza A
Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1265-9. PubMed ID: 21985539
[TBL] [Abstract][Full Text] [Related]
14. Induction of somatic cell reprogramming using the microRNA miR-302.
Kelley K; Lin SL
Prog Mol Biol Transl Sci; 2012; 111():83-107. PubMed ID: 22917227
[TBL] [Abstract][Full Text] [Related]
15. Induced Tissue-Specific Stem Cells (iTSCs): Their Generation and Possible Use in Regenerative Medicine.
Saitoh I; Sato M; Kiyokawa Y; Inada E; Iwase Y; Ibano N; Noguchi H
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34071015
[TBL] [Abstract][Full Text] [Related]
16. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
Imamura M; Hikabe O; Lin ZY; Okano H
Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
[TBL] [Abstract][Full Text] [Related]
17. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of human neuro-epithelial-like stem cells derived from induced pluripotent stem cells improves neurological function in rats with experimental intracerebral hemorrhage.
Qin J; Song B; Zhang H; Wang Y; Wang N; Ji Y; Qi J; Chandra A; Yang B; Zhang Y; Gong G; Xu Y
Neurosci Lett; 2013 Aug; 548():95-100. PubMed ID: 23680458
[TBL] [Abstract][Full Text] [Related]
20. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
